Upgrade to SI Premium - Free Trial

Sagimet Biosciences (SGMT)

6.76 -0.30 (4.25%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/19/26)

Latest Headlines

Form 8-K Sagimet Biosciences Inc. For: May 28 June 3, 2026 4:32 PM - SEC Filing Form 4 Sagimet Biosciences Inc. For: May 28 Filed by: Chauche Thierry June 1, 2026 9:16 PM - SEC Filing Form 4 Sagimet Biosciences Inc. For: May 28 Filed by: Grauer Andreas June 1, 2026 9:15 PM - SEC Filing Form 4 Sagimet Biosciences Inc. For: May 28 Filed by: Rozek Elizabeth June 1, 2026 9:15 PM - SEC Filing Form 4 Sagimet Biosciences Inc. For: May 28 Filed by: Happel David June 1, 2026 9:14 PM - SEC Filing Sagimet Biosciences Presents Two Posters at EASL 2026 on Denifanstat/Resmetirom Combination in MASH May 27, 2026 7:00 AM - StreetInsider Sagimet Biosciences Inc (SGMT) PT Lowered to $12 at Citizens on Acne Pivot May 19, 2026 4:10 AM - StreetInsider Form 4 Sagimet Biosciences Inc. For: Apr 20 Filed by: Grauer Andreas May 14, 2026 5:16 PM - SEC Filing Form 3 Sagimet Biosciences Inc. For: Apr 20 Filed by: Grauer Andreas May 14, 2026 5:14 PM - SEC Filing Sagimet Biosciences to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ May 13, 2026 7:00 AM - Globe NewsWire Form 8-K Sagimet Biosciences Inc. For: May 12 May 12, 2026 7:35 AM - SEC Filing Form 10-Q Sagimet Biosciences Inc. For: Mar 31 May 12, 2026 7:31 AM - SEC Filing Sagimet Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates May 12, 2026 7:30 AM - Globe NewsWire Sagimet Biosciences to Present Mechanism of Action Data for its FASN Inhibitors at the Society for Investigative Dermatology in Chicago May 11, 2026 7:00 AM - Globe NewsWire Sagimet Biosciences Inc (SGMT) PT Raised to $31 at Jones Trading May 4, 2026 7:10 AM - StreetInsider Sagimet Biosciences Inc (SGMT) PT Raised to $49 at Canaccord May 4, 2026 6:41 AM - StreetInsider Sagimet Biosciences Inc (SGMT) PT Raised to $33 at Oppenheimer April 30, 2026 5:26 PM - StreetInsider Form 8-K Sagimet Biosciences Inc. For: Apr 27 April 28, 2026 7:01 AM - SEC Filing Form 424B5 Sagimet Biosciences Inc. April 28, 2026 6:11 AM - SEC Filing Sagimet Biosciences Inc (SGMT) PT Raised to $28 at Oppenheimer April 27, 2026 11:29 AM - StreetInsider Form 8-K Sagimet Biosciences Inc. For: Apr 27 April 27, 2026 7:23 AM - SEC Filing Sagimet prices $175 million stock offering at $6 per share April 27, 2026 7:15 AM - StreetInsider Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock April 27, 2026 7:15 AM - Globe NewsWire Sagimet Biosciences plans Phase 3 acne trial for second half of 2026 April 27, 2026 7:01 AM - StreetInsider Form 8-K Sagimet Biosciences Inc. For: Apr 27 April 27, 2026 7:01 AM - SEC Filing Sagimet Biosciences Provides Strategic and Corporate Updates April 27, 2026 7:00 AM - StreetInsider Form ARS Sagimet Biosciences Inc. For: Dec 31 April 21, 2026 4:16 PM - SEC Filing Form DEF 14A Sagimet Biosciences Inc. For: Jun 12 April 21, 2026 4:11 PM - SEC Filing Form 8-K Sagimet Biosciences Inc. For: Apr 20 April 21, 2026 6:05 AM - SEC Filing Sagimet Biosciences names Andreas Grauer as chief medical officer April 20, 2026 7:01 AM - StreetInsider Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer April 20, 2026 7:00 AM - Globe NewsWire Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)( April 6, 2026 7:00 AM - Globe NewsWire Rodman & Renshaw Starts Sagimet Biosciences Inc (SGMT) at Buy March 26, 2026 6:32 AM - StreetInsider Sagimet Biosciences (SGMT) Reiterated at Market Outperform by Citizens March 12, 2026 5:30 AM - StreetInsider Oppenheimer Reiterates Outperform Rating on Sagimet Biosciences Inc (SGMT) following Q4 results March 11, 2026 4:04 PM - StreetInsider Form S-8 Sagimet Biosciences Inc. March 11, 2026 8:01 AM - SEC Filing Form S-8 Sagimet Biosciences Inc. March 11, 2026 7:59 AM - SEC Filing Form 8-K Sagimet Biosciences Inc. For: Mar 11 March 11, 2026 7:42 AM - SEC Filing Form 10-K Sagimet Biosciences Inc. For: Dec 31 March 11, 2026 7:31 AM - SEC Filing Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates March 11, 2026 7:30 AM - StreetInsider Full Article List